Simultaneous auto-transplant and CD19 CAR T-cell 2L therapy followed by a CD20 x CD3 bispecific antibody in a patient with refractory Burkitt lymphoma

Activity: Talk or presentation › Poster presentation › science-to-science

Period03 Dec 2024
Event titleunbekannt/unknown
Event typeConference
LocationAustriaShow on map

Fields of science

  • 302024 Haematology
  • 302055 Oncology